Αλτσχάιμερ: Με αυτόν τον τρόπο συνδέεται με την υγεία των δοντιών pronews.gr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pronews.gr Daily Mail and Mail on Sunday newspapers.
CBC Maliciously Mischaracterizes Epoch Times in Effort to Continue to Discredit the Outlet
Recently, some competitor media published biased, misleading reports about The Epoch Times. Please see our past response to NBC and The New York Times (click on the hyperlinked text).
On Jan. 29, the CBC published reports on The Epoch Times’ recent sampling edition delivered by Canada Post.
The national broadcaster’s report was the second top story on CBC’s website on the morning of Friday, Jan. 29, and was the first segment on CBC Radio’s World Report. It was also heavily promoted on CBC radio.
CBC is trying to discredit us by saying we’re covering “the QAnon conspiracy theory” in both its online report and early in its radio segment, which sets the tone for its reporting.
Jan 30, 2021
A wingsuit champion who grew up in Willenhall died by misadventure in a flying accident in Saudi Arabia, a coroner has ruled.
Subscribe to our daily newsletter!
Sign Up
Angelo Grubisic died in an accident (Image: Born to Engineer /Youtube)
Astronautical engineer Dr Angelo Grubisic, 38, died while taking part in a planned jump in the Middle East in August 2019, an inquest in Oldbury heard yesterday.
The talented scientist worked in Southampton but grew up in Willenhall, and attended Willenhall Comprehensive School, now known as Willenhall E-Act Academy, as a teenager.
Angelo had led a wingsuit design team at the University of Southampton where he lectured in astronautics and advanced propulsion.
E-Mail
(Singapore January 30, 2021 11:00 p.m. SPT/January 30, 2021 10:00 a.m. EST) Nivolumab monotherapy is an effective treatment option for relapsed malignant mesothelioma (MM), according to research presented today at the International Association for the Study of Lung Cancer World Conference on Lung Cancer.
Malignant mesothelioma is an intractable cancer, and no phase III trial has yet shown an improvement in overall survival following the standard first line chemotherapy doublet comprising pemetrexed and cisplatin or carboplatin since it was licensed in 2004.
Professor Dean Fennell, chair of Thoracic Medical Oncology at the University of Leicester in collaboration with Professor Gareth Griffiths and his team at the Southampton Clinical Trials Unit, University of Southampton, UK, presented results of the Checkpoint Blockade for Inhibition of Relapsed Mesothelioma (CONFIRM) study, funded by Cancer Research UK/Stand Up To Cancer. The investigator-led, placebo-controlled rando